Ameritas Investment Partners, Inc. - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 165 filers reported holding ANIKA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$22,393
-28.3%
1,2020.0%0.00%0.0%
Q2 2023$31,228
-9.5%
1,2020.0%0.00%0.0%
Q1 2023$34,521
-4.8%
1,2020.0%0.00%0.0%
Q4 2022$36,252
+29.5%
1,2020.0%0.00%0.0%
Q3 2022$28,000
+7.7%
1,2020.0%0.00%0.0%
Q2 2022$26,000
-13.3%
1,2020.0%0.00%0.0%
Q1 2022$30,000
-30.2%
1,2020.0%0.00%0.0%
Q4 2021$43,000
-15.7%
1,2020.0%0.00%
-50.0%
Q3 2021$51,000
-1.9%
1,2020.0%0.00%0.0%
Q2 2021$52,000
+6.1%
1,2020.0%0.00%0.0%
Q1 2021$49,000
-9.3%
1,2020.0%0.00%0.0%
Q4 2020$54,000
+25.6%
1,2020.0%0.00%0.0%
Q3 2020$43,000
-4.4%
1,2020.0%0.00%0.0%
Q2 2020$45,000
+28.6%
1,2020.0%0.00%0.0%
Q1 2020$35,000
-43.5%
1,2020.0%0.00%
-33.3%
Q4 2019$62,000
-6.1%
1,2020.0%0.00%0.0%
Q3 2019$66,000
+34.7%
1,2020.0%0.00%
+50.0%
Q2 2019$49,000
+36.1%
1,2020.0%0.00%0.0%
Q1 2019$36,000
-10.0%
1,2020.0%0.00%0.0%
Q4 2018$40,000
-21.6%
1,2020.0%0.00%0.0%
Q3 2018$51,000
+34.2%
1,2020.0%0.00%0.0%
Q2 2018$38,000
-33.3%
1,202
+5.3%
0.00%
-33.3%
Q1 2018$57,000
-8.1%
1,1420.0%0.00%0.0%
Q4 2017$62,000
+1.6%
1,1420.0%0.00%0.0%
Q3 2017$61,000
+8.9%
1,1420.0%0.00%0.0%
Q2 2017$56,000
+12.0%
1,1420.0%0.00%
+50.0%
Q1 2017$50,0001,1420.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Caligan Partners LP 1,081,360$20,145,7379.25%
Trigran Investments, Inc. 2,217,019$41,303,0654.40%
DIKER MANAGEMENT LLC 50,239$935,9530.84%
Virtus Investment Advisers, Inc. 45,579$849,1370.58%
Virtus Fund Advisers, LLC 3,490$65,0190.46%
CAPITAL MANAGEMENT CORP /VA 84,225$1,569,1120.35%
Riverwater Partners LLC 17,597$327,8320.30%
BOOTHBAY FUND MANAGEMENT, LLC 617,602$11,505,9250.27%
XTX Topco Ltd 28,033$522,2550.09%
GSA CAPITAL PARTNERS LLP 51,638$9620.08%
View complete list of ANIKA THERAPEUTICS INC shareholders